U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
Related Posts
Who owns your genes?
November 19, 2024
10:00 am
Energy & Utilities Roundup: Market Talk
November 19, 2024
9:51 am
12 coveted beauty gifts that are sure to delight – National | Globalnews.ca
November 19, 2024
9:46 am